Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
Leveraging AI in Drug Discovery: Elizabeth Schwarzbach of BigHat Biosciences, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
The Future of Activism and Shareholder Engagement: John Grau, CEO of InvestorCom, Live at NYSE
IPO Edge and CorpGov hosted a fireside chat from the floor of the New York...
The Smartest Road to an IPO: MorganFranklin Consulting’s Anil Persad, Live at NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with Anil...
Heating Up the Solid-State Cooling Game: Fireside with Phononic CEO Tony Atti, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Liquidity for Life Insurance: Join Fireside with CEO of Abacus Life Friday at 9AM ET
IPO Edge and the Palm Beach Hedge Fund Association will host a fireside chat with...
OLO Reshuffle Sets Company Up for Massive Opportunities Ahead
Olo Inc. (NYSE:OLO) restructuring on heels of strong balance sheet, solid Q1 Strategically reorganizing, centralizing...
HIGHLIGHTS – Democratizing Private Equity: Fireside Chat With CEO of Ben
IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with Beneficient,...
